Evidence map›Paper›PMID 41142186›Full record

ArticleUrology case reports2025

Primary malignant melanoma of the bladder: A rare case report.

Huber Díaz-Fuentes, Seiichi Fuziwara-Ruíz, Eduardo de Los Santos-Frias, Eduardo Amaya-Fragoso, Eduardo Rodríguez-Araujo, Eduardo Ramos-Arceo, Luis Aguirre-Amador, Cristopher Hernández-Rodríguez

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Urology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Huber Díaz-FuentesDepartment of Urology, Oncology Hospital, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Seiichi Fuziwara-RuízDepartment of Urology, Oncology Hospital, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Eduardo de Los Santos-FriasDepartment of Urology, Hospital Español de México, Mexico.
Eduardo Amaya-FragosoDepartment of Urology, Oncology Hospital, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Eduardo Rodríguez-AraujoDepartment of Urology, Oncology Hospital, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Eduardo Ramos-ArceoDepartment of Urology, Oncology Hospital, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Luis Aguirre-AmadorDepartment of Urology, Oncology Hospital, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Cristopher Hernández-RodríguezDepartment of Urology, Oncology Hospital, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report discusses a rare case of primary malignant melanoma of the bladder in a 71-year-old woman, presenting with dysuria, urinary frequency, and hematuria. A pedunculated mass at the urethral meatus was found, and an 8 cm exophytic bladder lesion was identified via ultrasound. Cystoscopy and histopathology confirmed the diagnosis. Despite a radical cystectomy, the patient passed away two months later. This case highlights a rare example of primary urinary bladder melanoma illustrating the value of an integrated clinical, imaging, and pathological approach in establishing the diagnosis and guide therapy of this rare but poorly behaved entity.

Indexed as

Bladder cancerMelanomaPrimary malignant melanomaUrinary bladder

Identifiers

PMID41142186
PMCPMC12549713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.